Family Practice NewsPerioperative infliximab does not increase serious infection riskFebruary 6, 2017RheumatologyDermatologyGastroenterology
Family Practice NewsHydroxychloroquine dosing guidelines have little impact in clinical practiceFebruary 2, 2017Rheumatology
Family Practice NewsVIDEO: Pattern recognition provides clues to rheumatologic diagnosesJanuary 31, 2017Rheumatology
Family Practice NewsFDA opens abbreviated approval pathway for interchangeable biosimilarsJanuary 26, 2017DermatologyOncologyRheumatology
Family Practice NewsBone fractures more likely to occur in psoriasis, PsA patientsJanuary 24, 2017DermatologyRheumatologyEndocrinologyPreventive Care
Family Practice NewsReports of new-onset joint pain differ after starting vedolizumabJanuary 24, 2017GastroenterologyRheumatology
Family Practice NewsSymptoms don’t worsen during pregnancy in most PsA patientsJanuary 23, 2017RheumatologyWomen's Health
Family Practice NewsGenetic studies link JIA subtypes to adult diseases, show uniqueness of systemic diseaseJanuary 17, 2017PediatricsRheumatologyMusculoskeletal Disorders
Family Practice NewsAll systemic steroid guidelines for RA offer little guidanceJanuary 12, 2017Rheumatology
Family Practice NewsMedicare payments set for infliximab biosimilar InflectraJanuary 10, 2017DermatologyRheumatologyGastroenterology
Family Practice NewsBariatric surgery or total joint replacement: which first?December 20, 2016ObesityRheumatology
Family Practice NewsOA drug development needs patient-focused approach to biomarkers and outcome measuresDecember 13, 2016Rheumatology
Family Practice NewsStrength of fibromyalgia as marker for seizures questionedDecember 9, 2016PainNeurologyRheumatology
Family Practice NewsLupus patients may be shortchanged on lipid managementDecember 7, 2016RheumatologyCardiology
Family Practice NewsTocilizumab raises cholesterol, but not cardiovascular eventsDecember 7, 2016RheumatologyCardiology